PT - JOURNAL ARTICLE AU - Phil A Crosbie AU - Haval Balata AU - Matthew Evison AU - Melanie Atack AU - Val Bayliss-Brideaux AU - Denis Colligan AU - Rebecca Duerden AU - Josephine Eaglesfield AU - Timothy Edwards AU - Peter Elton AU - Julie Foster AU - Melanie Greaves AU - Graham Hayler AU - Coral Higgins AU - John Howells AU - Klaus Irion AU - Devinda Karunaratne AU - Jodie Kelly AU - Zoe King AU - Judith Lyons AU - Sarah Manson AU - Stuart Mellor AU - Donna Miller AU - Amanda Myerscough AU - Tom Newton AU - Michelle O’Leary AU - Rachel Pearson AU - Julie Pickford AU - Richard Sawyer AU - Nick J Screaton AU - Anna Sharman AU - Maggi Simmons AU - Elaine Smith AU - Ben Taylor AU - Sarah Taylor AU - Anna Walsham AU - Angela Watts AU - James Whittaker AU - Laura Yarnell AU - Anthony Threlfall AU - Phil V Barber AU - Janet Tonge AU - Richard Booton TI - Second round results from the Manchester ‘Lung Health Check’ community-based targeted lung cancer screening pilot AID - 10.1136/thoraxjnl-2018-212547 DP - 2019 Jul 01 TA - Thorax PG - 700--704 VI - 74 IP - 7 4099 - http://thorax.bmj.com/content/74/7/700.short 4100 - http://thorax.bmj.com/content/74/7/700.full SO - Thorax2019 Jul 01; 74 AB - We report results from the second annual screening round (T1) of Manchester’s ‘Lung Health Check’ pilot of community-based lung cancer screening in deprived areas (undertaken June to August 2017). Screening adherence was 90% (n=1194/1323): 92% of CT scans were classified negative, 6% indeterminate and 2.5% positive; there were no interval cancers. Lung cancer incidence was 1.6% (n=19), 79% stage I, treatments included surgery (42%, n=9), stereotactic ablative radiotherapy (26%, n=5) and radical radiotherapy (5%, n=1). False-positive rate was 34.5% (n=10/29), representing 0.8% of T1 participants (n=10/1194). Targeted community-based lung cancer screening promotes high screening adherence and detects high rates of early stage lung cancer.